Australia markets open in 9 hours 29 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1200-0.1900 (-5.74%)
As of 10:31AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 489.26M
Enterprise value 276.88M
Trailing P/E 43.96
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.76
Price/book (mrq)1.78
Enterprise value/revenue 1.59
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-57.01%
S&P500 52-week change 323.33%
52-week high 39.0800
52-week low 32.2800
50-day moving average 33.0781
200-day moving average 34.2502

Share statistics

Avg vol (3-month) 31.75M
Avg vol (10-day) 31.43M
Shares outstanding 5147.37M
Implied shares outstanding 6147.37M
Float 881.72M
% held by insiders 12.02%
% held by institutions 1100.73%
Shares short (15 May 2024) 413.14M
Short ratio (15 May 2024) 47.21
Short % of float (15 May 2024) 411.45%
Short % of shares outstanding (15 May 2024) 48.92%
Shares short (prior month 15 Apr 2024) 410.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -123.24%
Operating margin (ttm)-116.45%

Management effectiveness

Return on assets (ttm)-17.10%
Return on equity (ttm)-61.58%

Income statement

Revenue (ttm)174.5M
Revenue per share (ttm)1.20
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA -171.15M
Net income avi to common (ttm)-215.06M
Diluted EPS (ttm)-1.4900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)308.87M
Total cash per share (mrq)2.1
Total debt (mrq)228.04M
Total debt/equity (mrq)82.99%
Current ratio (mrq)4.51
Book value per share (mrq)1.87

Cash flow statement

Operating cash flow (ttm)-135.52M
Levered free cash flow (ttm)-65.73M